These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 19809996)

  • 1. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
    Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
    J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired renal function and duration of dialysis therapy are associated with oxidative stress and proatherogenic cytokine levels in patients with end-stage renal disease.
    Pawlak K; Pawlak D; Mysliwiec M
    Clin Biochem; 2007 Jan; 40(1-2):81-5. PubMed ID: 17046733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
    Prakash M; Upadhya S; Prabhu R
    Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress markers in pre-uremic patients.
    Annuk M; Fellström B; Akerblom O; Zilmer K; Vihalemm T; Zilmer M
    Clin Nephrol; 2001 Oct; 56(4):308-14. PubMed ID: 11680661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment.
    Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxidative stress in end stage renal disease: evidence and association with cardiovascular events in Tunisian patients].
    Fellah H; Feki M; Souissi M; Ghorbel H; Ben Abdallah T; Massy Z; Hedhili A; Ben Maiz H; Lacour B; Kaabachi N; Mebazaa A
    Tunis Med; 2006 Nov; 84(11):724-9. PubMed ID: 17294900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis.
    Uzum A; Toprak O; Gumustas MK; Ciftci S; Sen S
    J Nephrol; 2006; 19(6):739-45. PubMed ID: 17173246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
    Morena M; Delbosc S; Dupuy AM; Canaud B; Cristol JP
    Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and oxidative stress in chronic renal failure.
    Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
    J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of erythrocyte structure and cellular susceptibility in patients with chronic renal failure: effect of haemodialysis and oxidative stress.
    Brzeszczynska J; Luciak M; Gwozdzinski K
    Free Radic Res; 2008 Jan; 42(1):40-8. PubMed ID: 18324522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein oxidative stress in dialysis patients.
    Doñate T; Herreros A; Martinez E; Martinez J; Andrés E; Cabezas A; Ortiz A; de Prado A; Pou JM; Pamplona R; Portero Otin M; Bellmunt MJ
    Adv Perit Dial; 2002; 18():15-7. PubMed ID: 12402579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
    Prakash M; Upadhya S; Prabhu R
    Clin Chim Acta; 2005 Oct; 360(1-2):194-8. PubMed ID: 15979061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients.
    Valentini J; Grotto D; Paniz C; Roehrs M; Burg G; Garcia SC
    Biomed Pharmacother; 2008; 62(6):378-82. PubMed ID: 18166291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.